4//SEC Filing
Biehl James 4
Accession 0000899243-22-031347
CIK 0001537917other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 6:00 PM ET
Size
26.6 KB
Accession
0000899243-22-031347
Insider Transaction Report
Form 4
Biehl James
Director
Transactions
- Disposition to Issuer
Common Stock
2022-09-16−105,000→ 0 total - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−500,000→ 0 totalExercise: $2.42Exp: 2028-09-08→ Common Stock (500,000 underlying) - Disposition to Issuer
Common Stock
2022-09-16−150→ 0 total(indirect: See Footnote) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−253,200→ 0 totalExercise: $1.56Exp: 2029-05-02→ Common Stock (253,200 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−500,000→ 0 totalExercise: $1.43Exp: 2031-06-13→ Common Stock (500,000 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−12,500→ 0 totalExercise: $2.95Exp: 2027-03-28→ Common Stock (12,500 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−360,000→ 0 totalExercise: $1.39Exp: 2030-05-06→ Common Stock (360,000 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−75,000→ 0 totalExercise: $2.90Exp: 2028-05-24→ Common Stock (75,000 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−482,200→ 0 totalExercise: $0.32Exp: 2032-04-21→ Common Stock (482,200 underlying) - Disposition to Issuer
Employee Stock Option - Option to buy
2022-09-16−12,500→ 0 totalExercise: $2.95Exp: 2027-03-28→ Common Stock (12,500 underlying)
Footnotes (11)
- [F1]Disposed of pursuant to the merger agreement between the issuer and Syros Pharmaceuticals, Inc. ("Syros") in exchange for 4,601 shares of Syros common stock having a market value of $7.30 per share at the close of trading on September 15, 2022, the last trading day immediately preceding the effective time of the merger, but after giving effect to a 1-for-10 reverse stock split by Syros (the "Reverse Split"), with cash paid in lieu of fractional shares.
- [F10]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 547 shares of Syros common stock for $67.32 per share, after giving effect to the Reverse Split.
- [F11]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 3,286 shares of Syros common stock for $66.18 per share, after giving effect to the Reverse Split.
- [F2]Disposed of pursuant to the merger agreement between the issuer and Syros in exchange for 6 shares of Syros common stock after giving effect to the Reverse Split, with cash paid in lieu of fractional shares.
- [F3]150 shares are owned by Mr. Biehl's spouse.
- [F4]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 21,910 shares of Syros common stock for $55.23 per share, after giving effect to the Reverse Split.
- [F5]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 11,095 shares of Syros common stock for $35.60 per share, after giving effect to the Reverse Split.
- [F6]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 15,775 shares of Syros common stock for $31.72 per share, after giving effect to the Reverse Split.
- [F7]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 21,910 shares of Syros common stock for $32.63 per share, after giving effect to the Reverse Split.
- [F8]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 21,130 shares of Syros common stock for $7.30 per share, after giving effect to the Reverse Split.
- [F9]This option was fully vested and assumed by Syros in the merger and replaced with an option to purchase 547 shares of Syros common stock for $67.32 per share, after giving effect to the Reverse Split.
Documents
Issuer
TYME TECHNOLOGIES, INC.
CIK 0001537917
Entity typeother
Related Parties
1- filerCIK 0001710484
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 6:00 PM ET
- Size
- 26.6 KB